RXO (NYSE:RXO) Price Target Lowered to $25.00 at Morgan Stanley

RXO (NYSE:RXO) had its target price dropped by research analysts at Morgan Stanley from $27.00 to $25.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target would indicate a potential upside of 20.22% from the stock’s current price.

A number of other research analysts also recently commented on the stock. Wells Fargo & Company lowered their price objective on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 7th. Susquehanna reduced their target price on shares of RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research note on Tuesday, November 12th. Benchmark reiterated a “hold” rating on shares of RXO in a research note on Wednesday, January 15th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $29.00 target price on shares of RXO in a research note on Monday, November 18th. Finally, Barclays reduced their target price on shares of RXO from $32.00 to $30.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $26.71.

RXO Trading Down 3.2 %

Shares of RXO stock traded down $0.69 during trading on Thursday, hitting $20.80. The stock had a trading volume of 141,975 shares, compared to its average volume of 1,042,899. The stock has a 50 day simple moving average of $25.96 and a 200 day simple moving average of $27.55. The company has a market capitalization of $3.34 billion, a PE ratio of -10.50, a P/E/G ratio of 3.98 and a beta of 1.53. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. RXO has a 1 year low of $18.75 and a 1 year high of $32.82.

RXO (NYSE:RXO) last released its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. On average, research analysts expect that RXO will post 0.12 EPS for the current fiscal year.

Institutional Investors Weigh In On RXO

A number of hedge funds have recently added to or reduced their stakes in the stock. Loomis Sayles & Co. L P acquired a new stake in shares of RXO in the 3rd quarter valued at approximately $27,964,000. Zimmer Partners LP acquired a new stake in shares of RXO in the 3rd quarter valued at approximately $22,680,000. Franklin Resources Inc. acquired a new stake in shares of RXO in the 3rd quarter valued at approximately $22,344,000. Victory Capital Management Inc. raised its position in shares of RXO by 1,772.4% in the 3rd quarter. Victory Capital Management Inc. now owns 761,230 shares of the company’s stock valued at $21,314,000 after acquiring an additional 720,574 shares during the period. Finally, State Street Corp raised its position in shares of RXO by 13.3% in the 3rd quarter. State Street Corp now owns 5,124,927 shares of the company’s stock valued at $143,498,000 after acquiring an additional 602,741 shares during the period. Institutional investors own 92.73% of the company’s stock.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.